Fig. 3From: Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virusViral titers from oral swabs in broiler chicks immunized with recombinant vaccine and challenged with HPAI virus in experiment 1. G1, G2, G3: 18-day-old embryonated eggs were vaccinated in ovo with PBS (Sham control; G1) or RP-H5 (G2) or rHVT-AI (G3). G4: Birds in G2 group were given an additional RP-H5 booster dose subcutaneously at 3 weeks of age. G5: Day old birds were vaccinated with both rHVT-AI and RP-H5 vaccine. Birds were challenged with A/turkey/Minnesota/12,582/2015(H5N2) clade 2.3.4.4 HPAI virus at either 3 weeks of age (Fig. 3A) or 6 weeks of age (Fig. 3B). Swabs were analyzed at 2 and 4 dpc using qRRT-PCR. Viral titers are expressed as log10 EID50/ml. Statistical differences are indicated by different lowercase lettering (P < 0.05)Back to article page